Date Title Format

10/05/2021

Report and Unaudited Financial Statements Year ended 31st December 2019

12/06/2019

Shareholder Update: One Year On From Transferring Colostrinin Rights To Sterling

HTML Page

13/06/2018

Sale of ‘Colostrinin’ Assets to Sterling Technology Inc.

HTML Page

04/11/2016

Unaudited Financial Statements Year 2015

HTML Page

01/10/2015

ReGen Therapeutics Ltd Year end Accounts 2014

HTML Page

05/11/2014

ReGen Therapeutics Limited. Report and Accounts 2013

09/12/2013

Shareholder Update 9th December 2013

HTML Page

30/09/2013

Report and Financial Statements – Year Ended December 2012

HTML Page

19/10/2012

ReGen Therapeutics Limited – Trading Update 19th October 2012

HTML Page

28/09/2012

Report and Financial Statements For The Twelve Months to 31st December 2011

HTML Page PDF

04/09/2012

Announcement of ReGen Therapeutics Update Meeting for Shareholders Monday 22nd October 2012

HTML Page

23/07/2012

Trading Update for the Twelve Months to 31st December

HTML Page

24/04/2012

Shareholder Bulletin

HTML Page

31/10/2011

Trading Update for the Six Months to 30 June 2011

HTML Page PDF

07/06/2011

Trading Statement

HTML Page

07/06/2011

Shareholder Bulletin

HTML Page

16/05/2011

ReGen Signs Test Marketing Agreement for its Nutraceutical Product Colostrinin(TM) in Brazil

HTML Page

28/04/2011

Shareholder Bulletin

HTML Page

04/04/2011

RGT Bulletin – 04 April 2011

HTML Page

11/03/2011

ReGen Appoints Regional Distributor for its Nutraceutical Product Colostrinin(TM) in the Middle East and North Africa (MENA) Region

HTML Page

18/02/2011

ReGen’s Colostrinin™ Moves to Convenient Daily Dosing Regimen in North America

HTML Page

18/02/2011

Completion of Demerger

HTML Page

17/02/2011

Result of Court Hearing

HTML Page

01/02/2011

Amendment to Timetable

HTML Page

01/02/2011

Total Voting Rights

HTML Page

28/01/2011

Result of General Meeting

HTML Page

12/01/2011

Form of Proxy – General Meeting

PDF

12/01/2011

Circular to shareholders – 12.01.11

PDF

12/01/2011

Posting of Circular, Placing and Notice of General Meeting

HTML Page PDFPDF

12/01/2011

Change of Adviser

HTML Page

31/12/2010

Total voting rights

HTML Page

15/12/2010

Agreement with Framingham Pharma

HTML Page

01/12/2010

Distributor Appointed in South Korea

HTML Page

30/09/2010

Total voting rights

HTML Page

23/09/2010

Issue of Equity

HTML Page

23/09/2010

Interim Results for the Six Months to 30 June 2010

PDF

30/07/2010

Total Voting Rights

HTML Page

29/07/2010

ReGen Purchases Filtration Unit

HTML Page

16/07/2010

Issue of Equity

HTML Page

07/07/2010

Colostrinin™ distribution agreement signed for India with USV Limited

HTML Page

30/06/2010

Total Voting Rights

HTML Page

28/06/2010

Result of AGM

HTML Page

28/06/2010

AGM Statement

HTML Page

25/06/2010

Issue of Equity

HTML Page

17/06/2010

ReGen appoints ICUK to assist developments in China

HTML Page

03/06/2010

Notice of AGM

PDFPDF

03/06/2010

Annual Report & Accounts 2009

PDF

28/05/2010

Total Voting Rights

HTML Page

20/05/2010

Preliminary Results for the year ended 31 December 2009

PDF

04/05/2010

Issue of Equity

HTML Page

04/05/2010

Colostrinin approved for marketing in Turkey

HTML Page

27/04/2010

Colostrinin distribution agreement signed for India

HTML Page

31/03/2010

Total Voting Rights

HTML Page

25/03/2010

Issue of Equity

HTML Page

11/03/2010

Result of General Meeting

HTML Page

01/03/2010

Colostrinin Update

HTML Page

23/02/2010

Notice of General Meeting

HTML Page PDFPDF

05/02/2010

Total Voting Rights

HTML Page

02/02/2010

Notification of Major Interest in Shares

PDF

22/01/2010

Trading Update

HTML Page

14/01/2010

Issue of Equity

HTML Page

13/01/2010

Notification of Major Interest in Shares

PDF

08/01/2010

Notification of Major Interest in Shares

PDF

17/12/2009

USA Sales Update

HTML Page

07/12/2009

Result of General Meeting and Update

HTML Page

30/11/2009

Total Voting Rights

HTML Page

18/11/2009

Notice of General Meeting

HTML Page PDFPDF

09/11/2009

Study confirms Zolpidem effect in brain damage

HTML Page

06/11/2009

Notification of major interest in shares

PDF

30/10/2009

Issue of Equity

HTML Page

22/10/2009

Notification of Major Interest in Shares

PDF

01/10/2009

PRG Nutraceuticals UK Launch

HTML Page

30/09/2009

Total Voting Rights

HTML Page

29/09/2009

Interim Results for the Six Months to 30 June 2009

PDF

22/09/2009

Notification of Major Interest in Shares

PDF

11/09/2009

Notification of Major Interest in Shares

PDF

08/09/2009

Notification of Major Interest in Shares

PDF

07/09/2009

Notification of Major Interest in Shares

PDF

02/09/2009

Issue of Equity

HTML Page

02/09/2009

Notification of Major Interest in Shares

PDF

28/08/2009

Total Voting Rights

HTML Page

28/08/2009

Notification of Major Interest in Shares

PDF

28/08/2009

Update on American Depositary Receipts

HTML Page

20/08/2009

Notification of Major Interest in Shares

PDF

20/08/2009

Issue of Equity

HTML Page

18/08/2009

UK Test Marketing Agreement

HTML Page

21/07/2009

Result of AGM and Chairman’s Statement

HTML Page

01/07/2009

Notification of Major Interest in Shares

PDF

30/06/2009

Notification of Major Interest in Shares

PDF

30/06/2009

Audited Accounts, Notice of AGM & TVR

PDF

27/06/2009

Notice of AGM

PDFPDF

27/06/2009

Annual Report and Accounts 2008

PDF

23/06/2009

Issue of Equity

HTML Page

17/06/2009

Notification of Major Interest in Shares

PDF

16/06/2009

Preliminary Results for the year ended 31 December 2008

PDF

15/06/2009

Notification of Major Interest in Shares

PDF

12/06/2009

Issue of Equity

HTML Page

10/06/2009

Notification of Major Interest in Shares

PDF

04/06/2009

Issue of Equity

HTML Page

02/06/2009

Notification of Major Interest in Shares

HTML Page
Get Adobe Reader If you are unable to view the PDF documents you may need to download the free Adobe Reader